Brief: Vanda Pharmaceuticals Q3 EPS USD -0.38
29/10/2025 20:01
Oct 29 (Reuters) - Vanda Pharmaceuticals Q3 operating income USD -31.284 million. Q3 net income USD -22.586 million Q3 basic EPS USD -0.38 Q3 operating expenses USD 87.542 million
Recent news on Vanda Pharmaceuticals
See all newsUS STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons
US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
US STOCKS ON THE MOVE-Nvidia, Penske Automotive, ManpowerGroup
US STOCKS ON THE MOVE-Barrick Mining, Venture Global, GE Vernova
Vanda Pharma shares slip as trial failure halts anxiety drug program